Infusystem Holdings Inc (INFU) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Infusystem Holdings Inc  (NYSEAMER: INFU)


Infusystem Holdings Inc's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Infusystem Holdings Inc's ROA in the second quarter of 2026?
Infusystem Holdings Inc achieved a return on average assets (ROA) of 8.63 % in its second quarter of 2026, this is above INFU's average return on assets of 1.05%.
Infusystem Holdings Inc assets over the 12 months ending in its second quarter of 2026 are valued at $99 million

ROA has improved compared to 7.93% in the first quarter of 2026, due to net income growth.

However, within the Healthcare sector 108 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 777, from total ROA ranking in the first quarter of 2026 at 1102.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -3.12 % -5.39 % -2.95 % -6.1 % -7.07 %
Y / Y Net Income Change 24.32 % - 118.22 % 25.01 % 262.48 %
Net Income (TTM) in million 9 8 7 6 5
Return On Assets (TTM) 8.63 % 7.93 % 6.55 % 5.42 % 4.9 %
INFU's Total Ranking # 777 # 1102 # 1121 # 1198 # 1576
Total Assets (TTM) in million 98 99 101 99 101
Seq. Total Assets Change -0.97 % -1.89 % 1.7 % -1.95 % -3.29 %
Seq. Net Income Change 217.7 % -50.05 % -9.87 % -13.08 % -

INFU's 5 Years Annual ROA >> Back to INFU Management Effectiveness >> Compare INFU ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 32
Sector # 109
Overall # 711

Return On Assets Statistics
High Average Low
20.93 %
1.05 %
-28.79 %
(Mar 31 2021)   (Sep 30 2018)





Financial Statements
Infusystem Holdings Inc's Assets $ 98 million INFU's Balance sheet
Infusystem Holdings Inc's Income $ 3 million Quarterly INFU's Income Statement
INFU's Income by Division See INFU's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -2.95 % 0.68 % 3.55 % 1.85 % 0.61 %
Total Assets in million 101 104 103 99 98
Y / Y Net Income Change 182.6 % 168.92 % 4744.44 % -98.73 % -91.81 %
Net Income in million 7 2 1 0 1
Annual Return On Assets 6.59 % 2.26 % 0.85 % 0.02 % 1.46 %

INFU's 5 Years Annual ROA >> Back to INFU Management Effectiveness >> Compare INFU ROA to its Competitors



Comment on INFU's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 6.59 % compared to prior year, due to annual net income growth of 182.6 % to $6.63 million, and due to decline of value in Infusystem Holdings Inc's assets by -2.95 % to $100.56 million, compared to $100.56 a year before.


More Return On Assets Ratios
INFU's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INFU's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for INFU's Competitors
Subscribers only: Roa for Infusystem Holdings Inc's Suppliers
Subscribers only: Return On Assets for INFU's Customers

You may also want to know
INFU's Roi INFU's Inventory Turnover Ratio INFU's Growth Rates INFU's Dividend Comparisons
INFU's Profitability Ratios INFU's Asset Turnover Ratio INFU's Dividend Growth
INFU's Roe INFU's Valuation Ratios INFU's Financial Strength Ratios INFU's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Eli Lilly And Company  21.97 %
Innoviva Inc   21.64 %
Vaxart Inc   20.85 %
Zevra Therapeutics Inc   20.39 %
Iradimed Corporation  20.36 %
Protalix Biotherapeutics inc   20.09 %
Pro dex Inc   19.87 %
Electromed Inc   19.39 %
United Therapeutics Corporation  17.98 %
Resmed Inc   17.80 %
Krystal Biotech Inc   17.65 %
Chemed Corporation  17.52 %
Zoetis Inc   17.19 %
Vertex Pharmaceuticals Inc  16.88 %
Halozyme Therapeutics Inc   16.55 %
Alnylam Pharmaceuticals Inc   15.76 %
Intuitive Surgical Inc   15.63 %
Healthcare Services Group Inc   15.21 %
Inspire Medical Systems inc   15.21 %
Dexcom Inc   14.87 %
Neurocrine Biosciences Inc   14.73 %
Entera Bio Ltd   14.60 %
Standard Biotools Inc   14.31 %
Arcutis Biotherapeutics Inc   14.23 %
Harmony Biosciences Holdings inc   14.15 %
Biolife Solutions Inc   14.09 %
Aveanna Healthcare Holdings Inc   13.82 %
West Pharmaceutical Services Inc   13.64 %
Medinotec Inc   13.38 %
Puma Biotechnology Inc   13.28 %

Date modified: 2026-09-26T06:50:52+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.